Literature DB >> 12360726

[Otomycosis due to Scopulariopsis brevicaulis].

M Besbes1, F Makni, F Cheikh-Rouhou, H Sellami, K Kharrat, A Ayadi.   

Abstract

We report a case of otomycosis due to Scopulariopsis brevicaulis in a patient with left cholesteatomatous chronic otitis media who presented with otorrhea associated with left otalgia. Scopulariopsis brevicaulis is a fungus which is rarely described as causing otomycosis although it is a saprophyte and widespread in the environment. In this case the contamination could be due to intensive gardening with poor hygiene. Its mycologic diagnosis is relatively easy and nystatin remains the most effective treatment in this region.

Entities:  

Mesh:

Year:  2002        PMID: 12360726

Source DB:  PubMed          Journal:  Rev Laryngol Otol Rhinol (Bord)        ISSN: 0035-1334


  5 in total

1.  Clinical usefulness of ELISPOT assay on pericardial fluid in a case of suspected tuberculous pericarditis.

Authors:  A Biglino; P Crivelli; E Concialdi; C Bolla; G Montrucchio
Journal:  Infection       Date:  2008-10-14       Impact factor: 3.553

2.  Effect of nystatin on Guinea Pigs' inner ear.

Authors:  Owen Woods; Issam Saliba
Journal:  Neurotox Res       Date:  2011-03-08       Impact factor: 3.911

3.  21-year retrospective study of the prevalence of Scopulariopsis brevicaulis in patients suspected of superficial mycoses.

Authors:  Anna B Macura; Magdalena Skóra
Journal:  Postepy Dermatol Alergol       Date:  2015-06-15       Impact factor: 1.837

4.  Etiologic Agents of Otomycosis in the North-Western Area of Iran.

Authors:  Abdolhassan Kazemi; Maryam Majidinia; Abbasali Jaafari; Seyyed Amin Ayatollahi Mousavi; Ali Zarei Mahmoudabadi; Hossein Alikhah
Journal:  Jundishapur J Microbiol       Date:  2015-09-08       Impact factor: 0.747

5.  Rapid Assays for Specific Detection of Fungi of Scopulariopsis and Microascus Genera and Scopulariopsis brevicaulis Species.

Authors:  Milena Kordalewska; Tomasz Jagielski; Anna Brillowska-Dąbrowska
Journal:  Mycopathologia       Date:  2016-06-02       Impact factor: 2.574

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.